Literature DB >> 1737461

Metabolic and anatomic thyroid emergencies: a review.

R C Smallridge1.   

Abstract

PURPOSE: To review the diagnosis and management of thyroid diseases, both metabolic (thyroid storm and myxedema coma) and anatomic (substernal goiter, lymphoma, anaplastic carcinoma) that may require intensive care therapy. DATA SOURCES: English-language articles were identified through a search of the MEDLINE and Index Medicus databases. Bibliographies of retrieved articles were examined for relevant articles. STUDY SELECTION: Approximately 250 articles were reviewed. Those articles deemed most representative were utilized. Case reports were included to highlight rare, but potentially lethal complications. DATA EXTRACTION: All data were analyzed by one observer. Limitations of the data are discussed. DATA SYNTHESIS: Guidelines for determining the etiology of thyrotoxic crisis are outlined. Criteria for distinguishing critically ill hypothyroid patients from those patients with the euthyroid sick syndrome are given. Therapy for both disorders must be aggressive and multifaceted, and detailed management is indicated. Substernal goiter is almost always benign, but may cause various acute complications, including dyspnea, respiratory failure, superior vena caval syndrome, esophageal varices (downhill), and others. Surgery almost always corrects the problem. Lymphomas present with rapid thyroid enlargement. Recent studies suggest that surgery may assume more of a supportive role, used principally to obtain adequate tissue for histologic classification.
CONCLUSIONS: Thyroid disorders can produce emergencies requiring the attention of multiple medical and surgical specialists. While management is often successful, future studies should address the following three areas: a) optimization of thyroid hormone dose for treatment of myxedema coma; b) clarification of the role of radiotherapy and/or chemotherapy for thyroid lymphoma; and c) more effective therapy for anaplastic carcinoma.

Entities:  

Mesh:

Year:  1992        PMID: 1737461     DOI: 10.1097/00003246-199202000-00016

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  6 in total

Review 1.  Myxedema coma.

Authors:  Eric Fliers; Wilmar M Wiersinga
Journal:  Rev Endocr Metab Disord       Date:  2003-05       Impact factor: 6.514

2.  Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement.

Authors:  Jacqueline Jonklaas; Antonio C Bianco; Andrew J Bauer; Kenneth D Burman; Anne R Cappola; Francesco S Celi; David S Cooper; Brian W Kim; Robin P Peeters; M Sara Rosenthal; Anna M Sawka
Journal:  Thyroid       Date:  2014-12       Impact factor: 6.568

3.  Relations between the selenium status and the low T3 syndrome after major trauma.

Authors:  M M Berger; T Lemarchand-Béraud; C Cavadini; R Chioléro
Journal:  Intensive Care Med       Date:  1996-06       Impact factor: 17.440

4.  Therapeutic approach to "downhill" esophageal varices bleeding due to superior vena cava syndrome in Behcet's disease: a case report.

Authors:  Hamid Tavakkoli; Mehrnaz Asadi; Mahshid Haghighi; Abbas Esmaeili
Journal:  BMC Gastroenterol       Date:  2006-12-27       Impact factor: 3.067

5.  Management of concomitant metabolic encephalopathy and meningioma with vasogenic edema and impending herniation.

Authors:  Ramsis F Ghaly; Armen Haroutunian; Kenneth D Candido; Nebojsa Nick Knezevic
Journal:  Surg Neurol Int       Date:  2018-02-08

Review 6.  Clinical concepts on thyroid emergencies.

Authors:  Giampaolo Papi; Salvatore Maria Corsello; Alfredo Pontecorvi
Journal:  Front Endocrinol (Lausanne)       Date:  2014-07-01       Impact factor: 5.555

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.